Bioforce Nanosciences Holdings, Inc. Sample Contracts

AutoNDA by SimpleDocs
EXHIBIT 2.1 ----------- AGREEMENT AND PLAN OF MERGER
Agreement and Plan of Merger • March 2nd, 2006 • Bioforce Nanosciences Holdings, Inc. • Mining & quarrying of nonmetallic minerals (no fuels) • Delaware
CITY OF AMES ECONOMIC DEVELOPMENT REVOLVING LOAN FUND PROGRAM LOAN AGREEMENT (BIOFORCE NANOSCIENCES, INC.)
Loan Agreement • April 2nd, 2007 • Bioforce Nanosciences Holdings, Inc. • Laboratory analytical instruments • Iowa
ECONOMIC DEVELOPMENT COMMUNITY INVESTMENT FUND PROGRAM LOAN AGREEMENT (BIOFORCE NANOSCIENCES, INC.)
Bioforce Nanosciences Holdings, Inc. • April 2nd, 2007 • Laboratory analytical instruments • Iowa
Contract
Warrant Purchase Agreement • November 20th, 2008 • Bioforce Nanosciences Holdings, Inc. • Laboratory analytical instruments • Delaware

THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED ABSENT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR COMPLIANCE WITH AN AVAILABLE EXEMPTION FROM REGISTRATION. THE COMPANY MAY REFUSE TO AUTHORIZE ANY TRANSFER OF THE SECURITIES IN RELIANCE ON AN EXEMPTION FROM REGISTRATION UNTIL IT HAS RECEIVED AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.

SUBSCRIPTION AGREEMENT
Subscription Agreement • May 4th, 2020 • Bioforce Nanosciences Holdings, Inc. • Laboratory analytical instruments

The undersigned, Richard Kaiser, hereby subscribes to 500,000 shares of the $0.0001 par value Preferred Series ‘A’ stock (the "Shares") of BioForce Nanosciences Holdings, Inc. (BFNH) a corporation duly organized under the laws of the State of Nevada, (the "Company").

to
Commercial Lease • October 1st, 2007 • Bioforce Nanosciences Holdings, Inc. • Laboratory analytical instruments
AMENDMENT NUMBER 1 to EMPLOYMENT AGREEMENT
Employment Agreement • August 14th, 2007 • Bioforce Nanosciences Holdings, Inc. • Laboratory analytical instruments
Director/ Chief Financial Officer/ Secretary Compensation AGREEMENT
Confidentiality Agreement • May 4th, 2020 • Bioforce Nanosciences Holdings, Inc. • Laboratory analytical instruments • Delaware

This Director, Chief Financial Officer/ Secretary (DCFOS) Compensation Agreement (this “Agreement”) is made as of the 31st day of March 2020 by and among Bioforce Nanosciences Holdings, Inc. (BFNH) a Delaware Corporation, having its principal place of business at 2020 General Booth Blvd., Unit 230 Virginia Beach, VA 23454 (“Company”), and Richard Kaiser Director, Chief Financial Officer/ Secretary, and is made in light of the following recitals which are a material part hereof.

AutoNDA by SimpleDocs
CONVERTIBLE SECURED PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENT
Note and Warrant Purchase Agreement • November 20th, 2008 • Bioforce Nanosciences Holdings, Inc. • Laboratory analytical instruments • Delaware

This CONVERTIBLE SECURED PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENT (the “Agreement”) is dated as of November 17, 2008 by and among BioForce Nanosciences Holdings, Inc., a Nevada corporation (the “Company”), and each of the Purchasers of Units, as described below, whose names are set forth on Exhibit A hereto (individually, a “Purchaser” and collectively, the “Purchasers”).

CONSULTING AGREEMENT
Consulting Agreement • July 30th, 2021 • Bioforce Nanosciences Holdings, Inc. • Laboratory analytical instruments • Virginia
Contract
Bioforce Nanosciences Holdings, Inc. • November 20th, 2008 • Laboratory analytical instruments

THIS NOTE AND THE SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED ABSENT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR COMPLIANCE WITH AN AVAILABLE EXEMPTION FROM REGISTRATION. THE COMPANY MAY REFUSE TO AUTHORIZE ANY TRANSFER OF THE SECURITIES IN RELIANCE ON AN EXEMPTION FROM REGISTRATION UNTIL IT HAS RECEIVED AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.

SERIES A CONVERTIBLE PREFERRED STOCK AND WARRANT PURCHASE
Convertible Preferred Stock and Warrant Purchase • September 7th, 2007 • Bioforce Nanosciences Holdings, Inc. • Laboratory analytical instruments • Delaware
Amendment Number 1 to Employment Agreement
Employment Agreement • November 12th, 2008 • Bioforce Nanosciences Holdings, Inc. • Laboratory analytical instruments

This Amendment Number 1 (the “Amendment”) dated November 10, 2008, amends the Employment Agreement (the “Agreement”) between BioForce Nanosciences Holdings, Inc. (the “Company”) and Gregory D. Brown (the “Employee”)

EMPLOYMENT AGREEMENT
Employment Agreement • August 13th, 2008 • Bioforce Nanosciences Holdings, Inc. • Laboratory analytical instruments • Iowa

EMPLOYMENT AGREEMENT (this “Agreement”) effective as of September 1, 2008 between BioForce Nanosciences Holdings, Inc (the “Company”), a Nevada corporation, and Eric R. Henderson (the “Employee”), a resident of the State of Iowa.

AMENDMENT NUMBER 2 to the October 14, 2002 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • May 15th, 2008 • Bioforce Nanosciences Holdings, Inc. • Laboratory analytical instruments

This Amendment Number 2 to the October 14, 2002 Amended and Restated Registration Rights Agreement ( “Amendment Number 2”), made effective as of May 5, 2008, is by and between the Holders and BioForce Nanosciences Holdings, Inc. (the “Company”), as successor to BioForce Nanosciences, Inc.

Contract
Bioforce Nanosciences Holdings, Inc. • July 24th, 2008 • Laboratory analytical instruments

THIS NOTE AND THE SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED ABSENT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR COMPLIANCE WITH AN AVAILABLE EXEMPTION FROM REGISTRATION. THE COMPANY MAY REFUSE TO AUTHORIZE ANY TRANSFER OF THE SECURITIES IN RELIANCE ON AN EXEMPTION FROM REGISTRATION UNTIL IT HAS RECEIVED AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.

RSDL ENTERPRISES CONSULTING AGREEMENT
RSDL Enterprises Consulting Agreement • July 22nd, 2020 • Bioforce Nanosciences Holdings, Inc. • Laboratory analytical instruments • Virginia
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!